Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)

 Full screen view
Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
MMAC-SF Vemurafenib Dasatinib 0.000 3.160
uM
 72
hr
 2 939 30 0.6962 0.7322 0.0319 0.0524
MMAC-SF Vemurafenib Dasatinib 0.000 3.160
uM
 72
hr
 3 753 46 0.5415 0.7322 0.0611 0.0524
MMAC-SF Vemurafenib Dasatinib 0.100 3.160
uM
 72
hr
 1 1039 59 0.7506 0.6145 0.0568 0.0615
MMAC-SF Vemurafenib Dasatinib 0.100 3.160
uM
 72
hr
 2 896 69 0.6334 0.6145 0.0770 0.0615
MMAC-SF Vemurafenib Dasatinib 0.100 3.160
uM
 72
hr
 3 632 32 0.4595 0.6145 0.0506 0.0615
WM-115 Vemurafenib Dasatinib 1.000 3.160
uM
 72
hr
 3 1251 376 0.2184 0.2060 0.3006 0.3157
WM-115 Vemurafenib Dasatinib 1.000 3.160
uM
 72
hr
 2 1210 394 0.2037 0.2060 0.3256 0.3157
WM-115 Vemurafenib Dasatinib 1.000 3.160
uM
 72
hr
 1 1156 371 0.1960 0.2060 0.3209 0.3157
A-375 Vemurafenib JNK-IN-8 0.100 3.160
uM
 72
hr
 3 2345 209 0.1344 0.1826 0.0891 0.0764
A-375 Vemurafenib JNK-IN-8 0.100 3.160
uM
 72
hr
 2 3262 246 0.1897 0.1826 0.0754 0.0764